TD Waterhouse Canada’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.4M Sell
54,840
-15,871
-22% -$3.01M 0.07% 185
2025
Q1
$14.6M Buy
70,711
+15,113
+27% +$3.11M 0.12% 150
2024
Q4
$9.88M Buy
55,598
+4,133
+8% +$735K 0.08% 188
2024
Q3
$10.1M Sell
51,465
-20,437
-28% -$4.02M 0.08% 181
2024
Q2
$12.3M Buy
71,902
+1,223
+2% +$208K 0.11% 159
2024
Q1
$13.3M Sell
70,679
-8,206
-10% -$1.55M 0.1% 163
2023
Q4
$13.3M Sell
78,885
-15,369
-16% -$2.58M 0.12% 135
2023
Q3
$14.4M Sell
94,254
-4,733
-5% -$725K 0.15% 113
2023
Q2
$13.9M Sell
98,987
-94,142
-49% -$13.3M 0.14% 116
2023
Q1
$31.8M Buy
193,129
+25,577
+15% +$4.21M 0.33% 59
2022
Q4
$27.9M Buy
167,552
+597
+0.4% +$99.4K 0.31% 60
2022
Q3
$23.6M Sell
166,955
-49,940
-23% -$7.05M 0.27% 67
2022
Q2
$34M Sell
216,895
-31,330
-13% -$4.91M 0.38% 49
2022
Q1
$39.7M Buy
248,225
+10,873
+5% +$1.74M 0.39% 54
2021
Q4
$31.7M Buy
+237,352
New +$31.7M 0.31% 66